| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-14 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.27 | 6e-13 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-10 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.27 | 4e-08 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.24 | 1e-06 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |